| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |